{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:40:57Z","timestamp":1780112457955,"version":"3.54.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/neuonc\/nor114","type":"journal-article","created":{"date-parts":[[2011,8,20]],"date-time":"2011-08-20T00:44:49Z","timestamp":1313801089000},"page":"1225-1233","source":"Crossref","is-referenced-by-count":29,"title":["Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases"],"prefix":"10.1093","volume":"13","author":[{"given":"David","family":"Scheie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torstein R.","family":"Meling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada","family":"Cvancarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Skullerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"M\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Lote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor J.","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Beiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"key":"key\n\t\t\t\t20170508164225_NOR114C1","volume-title":"WHO classification of tumors of the central nervous system","author":"Louis","year":"2007"},{"key":"key\n\t\t\t\t20170508164225_NOR114C2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3171\/jns.1985.63.6.0881","article-title":"Oligodendroglioma: incidence and biological behavior in a defined population","volume":"63","author":"Mork","year":"1985","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170508164225_NOR114C3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/modpathol.3880400","article-title":"Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections","volume":"14","author":"Burger","year":"2001","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jnen\/60.3.248","article-title":"Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading","volume":"60","author":"Giannini","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1750-3639.2002.tb00440.x","article-title":"What is an oligodendroglioma?","volume":"12","author":"Burger","year":"2002","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.55418\/9781933477015-ch03","article-title":"Tumors of neuroglia and choroid plexus","volume-title":"AFIP Atlas of Tumor Pathology. Tumors of the Central Nervous System","author":"Burger","year":"2007","edition":"4th ed."},{"key":"key\n\t\t\t\t20170508164225_NOR114C7","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402","volume":"24","author":"Cairncross","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C8","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","article-title":"Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial","volume":"24","author":"van den Bent","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C9","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1200\/JCO.2006.05.9238","article-title":"Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy","volume":"24","author":"Mariani","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/cncr.21338","article-title":"The prognostic impact of histology and 1p\/19q status in anaplastic oligodendroglial tumors","volume":"104","author":"McDonald","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170508164225_NOR114C11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnen\/62.11.1118","article-title":"Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial\/astrocytic features","volume":"62","author":"Fuller","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C12","doi-asserted-by":"crossref","first-page":"a1","DOI":"10.2741\/896","article-title":"Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics","volume":"8","author":"Perry","year":"2003","journal-title":"Front Biosci"},{"key":"key\n\t\t\t\t20170508164225_NOR114C13","first-page":"6205","article-title":"Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma","volume":"62","author":"Burton","year":"2002","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508164225_NOR114C14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2559.2008.03160.x","article-title":"Can morphology predict 1p\/19q loss in oligodendroglial tumors?","volume":"53","author":"Scheie","year":"2008","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20170508164225_NOR114C15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.pas.0000213250.44822.2e","article-title":"Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors","volume":"30","author":"Scheie","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C16","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1200\/JCO.2006.08.1497","article-title":"Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas","volume":"24","author":"Miller","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1227\/00006123-199404000-00002","article-title":"Mixed oligoastrocytomas: a survival and prognostic factor analysis","volume":"34","author":"Shaw","year":"1994","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t20170508164225_NOR114C18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0404.2010.01350.x","article-title":"Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme","volume":"122","author":"Helseth","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20170508164225_NOR114C19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnen\/60.9.863","article-title":"Glioblastomas with an oligodendroglial component: a pathological and molecular study","volume":"60","author":"He","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.jnen.0000235118.75182.94","article-title":"Correlation among pathology, genotype, and patient outcomes in glioblastoma","volume":"65","author":"Homma","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s004010000258","article-title":"Molecular genetic alterations in glioblastomas with oligodendroglial component","volume":"101","author":"Kraus","year":"2001","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0090-3019(03)00167-8","article-title":"Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis","volume":"60","author":"Engelhard","year":"2003","journal-title":"Surg Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1227\/00006123-199406000-00002","article-title":"Oligodendroglioma: the Rotterdam-Dijkzigt experience","volume":"34","author":"Kros","year":"1994","journal-title":"Neurosurgery"},{"key":"key\n\t\t\t\t20170508164225_NOR114C25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/jns.1992.76.3.0428","article-title":"Oligodendrogliomas: the Mayo Clinic experience","volume":"76","author":"Shaw","year":"1992","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170508164225_NOR114C26","first-page":"6713","article-title":"Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms","volume":"61","author":"Zlatescu","year":"2001","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508164225_NOR114C27","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508164225_NOR114C28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-7-41","article-title":"Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile","volume":"7","author":"Ducray","year":"2008","journal-title":"Mol Cancer"},{"key":"key\n\t\t\t\t20170508164225_NOR114C30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11060-009-9944-y","article-title":"Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression","volume":"95","author":"Ferrer-Luna","year":"2009","journal-title":"J Neurooncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C31","first-page":"4277","article-title":"Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas","volume":"52","author":"von Deimling","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508164225_NOR114C32","first-page":"1397","article-title":"Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q","volume":"54","author":"von Deimling","year":"1994","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170508164225_NOR114C33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1750-3639.2008.00129.x","article-title":"Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402","volume":"18","author":"Giannini","year":"2008","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2004.101.2.0219","article-title":"The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme","volume":"101","author":"Shinojima","year":"2004","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170508164225_NOR114C35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(19900915)66:6<1204::AID-CNCR2820660621>3.0.CO;2-A","article-title":"Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas","volume":"66","author":"Kros","year":"1990","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170508164225_NOR114C36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170508164225_NOR114C37","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/cncr.20867","article-title":"Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance","volume":"103","author":"Claus","year":"2005","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170508164225_NOR114C38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3171\/jns.2003.99.5.0854","article-title":"Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993","volume":"99","author":"Johannesen","year":"2003","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170508164225_NOR114C39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01052654","article-title":"Oligodendrogliomas: clinicopathological correlations","volume":"24","author":"Kros","year":"1995","journal-title":"J Neurooncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/13\/11\/1225\/16663318\/nor114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:05:34Z","timestamp":1686261934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nor114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,8,19]]},"published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nor114","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,19]]}}}